Want to see HUM full AI Analyst Report?
HUM Stock Chart & Stats
$389.71
-$6.72(-1.73%)
At close: 4:00 PM EDT
$389.71
-$6.72(-1.73%)
Day’s Range― - ―
52-Week Range$163.11 - $456.50
Previous CloseN/A
Volume391.94K
Average Volume (3M)1.13M
Market Cap
$51.86B
Enterprise Value$62.43B
Total Cash (Recent Filing)$23.87B
Total Debt (Recent Filing)$14.25B
Price to Earnings (P/E)40.5
Beta1.03
Next Earnings
Nov 06, 2026Next Dividend Ex-DateN/A
Dividend Yield0.82%
Share Statistics
EPS (TTM)10.65
Shares Outstanding120,080,310
10 Day Avg. Volume1,630,442
30 Day Avg. Volume1,125,004
Financial Highlights & Ratios
PEG Ratio-18.55
Price to Book (P/B)1.75
Price to Sales (P/S)0.24
P/FCF Ratio82.27
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue0.43
Enterprise Value/Gross Profit3.14
Enterprise Value/Ebitda20.15
Forecast
1Y Price Target
$457.57Price Target Upside17.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering23
EPS Forecast (FY)9.16
Revenue Forecast (FY)$162.52B
Bulls Say, Bears Say
Bulls Say
Improved Medicare Advantage Star RatingsHigher Star Ratings strengthen Humana’s Medicare Advantage competitiveness and support quality-linked revenue. Broader enrollment in highly rated plans can improve member retention, plan appeal, and bonus economics, reinforcing the company’s position in its core government-backed market.
Operating Cost ReductionMeasured reductions in the operating cost ratio show that management is executing structural efficiency initiatives rather than relying only on favorable claims experience. Lower administrative costs can provide recurring support for margins, fund member investments, and improve earnings resilience as revenue grows.
Steady Revenue ExpansionSustained revenue expansion indicates continued scale in Humana’s insurance and healthcare-services platforms. A growing top line broadens the earnings base and creates operating leverage opportunities, while the company’s Medicare focus and new Medicaid presence support participation in large government-backed markets.
Bears Say
Compressed ProfitabilityThin and reduced margins leave less room to absorb medical-cost or pharmacy-cost pressure and make earnings more sensitive to underwriting execution. The decline from earlier profitability also weakens returns on equity, meaning revenue growth has not yet translated into comparable shareholder returns.
Elevated Drug Cost TrendPersistent double-digit drug inflation can raise claim costs faster than premiums or government payments adjust, creating a direct and durable underwriting headwind. It may require tighter benefit design, pricing discipline, or cost-management actions, while limiting the pace of margin recovery.
Medicare Advantage Plan ExitsExiting plans will disrupt a meaningful member base and create retention and transition risk even if Humana recaptures part of the membership. The shift may also alter the mix toward higher-performing plans, but the scale of disruption makes near-term growth and margin outcomes more dependent on execution.
HUM FAQ
What was Humana Inc’s price range in the past 12 months?
Humana Inc lowest stock price was $163.11 and its highest was $456.50 in the past 12 months.
What is Humana Inc’s market cap?
Humana Inc’s market cap is $51.86B.
When is Humana Inc’s upcoming earnings report date?
Humana Inc’s upcoming earnings report date is Nov 06, 2026 which is in 25 days.
How were Humana Inc’s earnings last quarter?
Humana Inc released its earnings results on Jul 29, 2026. The company reported $7.61 earnings per share for the quarter, beating the consensus estimate of $7.268 by $0.342.
Is Humana Inc overvalued?
According to Wall Street analysts Humana Inc’s price is currently Undervalued.
Does Humana Inc pay dividends?
Humana Inc pays a Quarterly dividend of $0.885 which represents an annual dividend yield of 0.82%. See more information on Humana Inc dividends here
What is Humana Inc’s EPS estimate?
Humana Inc’s EPS estimate is -1.
How many shares outstanding does Humana Inc have?
Humana Inc has 120,080,310 shares outstanding.
What happened to Humana Inc’s price movement after its last earnings report?
Humana Inc reported an EPS of $7.61 in its last earnings report, beating expectations of $7.268. Following the earnings report the stock price went down -5.994%.
Which hedge fund is a major shareholder of Humana Inc?
Currently, no hedge funds are holding shares in HUM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Humana Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$457.57 (17.41% Upside)
$457.57 (17.41% Upside)
Blogger Sentiment
Bullish
HUM Sentiment 77%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 553.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.9%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
News Sentiment
Very Bullish
Bullish news 97%
Bearish news 3%
Bearish news 3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.23%
12-Months-Change
Fundamentals
Return on Equity
6.91%
Trailing 12-Months
Asset Growth
13.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Humana Inc
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
HUM Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally constructive operational and strategic progress narrative: clear cost-reduction execution (120 bps Y/Y improvement in Q2 operating cost ratio and expected ~150 bps full-year), tangible improvement in key Stars-related measures (outperforming historical CAGR on most selected metrics and ~5% better quality improvement rate for BY '29 measures), balance-sheet moves (Gentiva divestiture ~ $900M and $1.5B P-Cap facilities) and a new statewide Medicaid win. However, material risks remain — notably elevated and rising drug trend, dependence on membership mix for margin realization, plan-exit disruption (~600k members), elevated reserves/IBNR, and Stars/ policy uncertainty — which temper the outlook. On balance, the highlights (execution, cost savings, Stars operational progress, capital actions) outweigh the lowlights (policy uncertainty, drug trend, membership disruption), producing a cautiously positive sentiment.View all HUM earnings summariesHUM Revenue Breakdown
94.73% Premiums
4.50% Services
0.78% Investment income

HUM Stock 12 Month Forecast
Average Price Target
$457.57
▲(17.41% Upside)
Technical Analysis
Ownership Overview
0.27% Insiders
35.99% Mutual Funds
0.13% Other Institutional Investors
32.58% Public Companies and
Individual Investors











